P&G Earnings Show Mixed Q2 Results

P&G earnings showed a $22.2 billion Q2 revenue miss and a $1.88 core EPS beat, signaling near-term top-line pressure and trading risk.

January 22, 2026·2 min read
View all news articles
Flat vector of a household product bottle with reduced fill, representing P&G earnings mixed top-line margin signals.

KEY TAKEAWAYS

  • P&G posted Q2 net sales of $22.2 billion, missing Street consensus.
  • Core EPS of $1.88 beat estimates while volumes declined across key categories.
  • Company maintained fiscal-2026 guidance but flagged restructuring-related EPS pressure and top-line risk.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Procter & Gamble’s fiscal second-quarter results on Jan. 22 showed mixed performance as pricing supported a slight sales increase while volumes and U.S. demand in grooming and baby care weakened. The company left its fiscal 2026 outlook broadly unchanged.

Second-Quarter Results

The company said in a press release that net sales for the quarter ending Dec. 31, 2025, were $22.2 billion, up 1.0% from the prior year but below the Street consensus of about $22.3 billion, marking a P&G revenue miss. Organic sales were flat year over year, with roughly 1.0 percentage point of price increases offset by a 1.0 percentage-point volume decline.

Core earnings per share (EPS) were $1.88, flat year over year and above expectations of about $1.86–$1.87, delivering a core EPS beat. This earnings resilience contrasted with the revenue shortfall and softer volumes across several categories, signaling near-term top-line risk.

Reported diluted net EPS fell 5.0% to $1.78, weighed down by incremental restructuring charges. Reported net earnings declined 7.0% to $4.3 billion. Core gross margin contracted 50 basis points year over year (currency-neutral down 30 basis points), and core operating margin fell 70 basis points (currency-neutral down 80 basis points), indicating margin pressure despite pricing actions.

Operating cash flow totaled $5.0 billion, providing flexibility as management balances cost controls and pricing.

By segment, organic sales rose 4.0% in Beauty and 3.0% in Health Care. Grooming and Fabric & Home Care were unchanged, while Baby, Feminine & Family Care declined 4.0% due to volume drops. Management cited weak U.S. consumer spending in laundry detergent, toilet paper, razors, and diapers as factors behind the softness.

Guidance and Outlook

Procter & Gamble maintained its fiscal 2026 guidance, forecasting all-in sales growth of 1.0% to 5.0%, including about a one-percentage-point tailwind from foreign exchange and acquisitions or divestitures. Organic sales are expected to be flat to up 4.0%. Core EPS growth is projected flat to up 4.0%, while diluted net EPS growth was lowered to 1.0% to 6.0% from a prior 3.0% to 9.0% range, partly due to restructuring charges.

Commodity costs are expected to be neutral. Foreign-exchange effects should provide an after-tax tailwind of roughly $200 million, while tariffs will create an after-tax headwind of about $400 million, or approximately $0.19 per share. Management said it remains on track to meet guidance and anticipates a stronger second half.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Google AI Zero-Day Attack Thwarted

Google AI Zero-Day Attack Thwarted

Google AI zero-day incident highlights a new class of cyber risk and may push investors to reweight security exposure in software and cloud stocks.

Cerebras IPO Upsized Amid Strong Demand

Cerebras IPO Upsized Amid Strong Demand

Cerebras IPO was upsized on May 11, 2026 as demand surged, expanding the offering and valuation and drawing near-term trading interest for Nasdaq debut.

Circle Q1 Earnings Show USDC Momentum

Circle Q1 Earnings Show USDC Momentum

Circle Q1 earnings showed USDC circulation and on-chain volume accelerating, lifting reserve income even as net income fell and spurring investor flows.

Monday.com Q1 2026 Results Signal AI Push

Monday.com Q1 2026 Results Signal AI Push

monday.com Q1 2026 results pair 24% revenue growth and record GAAP operating income with an AI Work Platform and OneAI deal, supporting share gains.

Moderna Stock Surge After Cruise Hantavirus Cases

Moderna Stock Surge After Cruise Hantavirus Cases

Moderna stock surge sent biotech peers higher as MV Hondius hantavirus reports spurred premarket trading despite WHO and CDC assessments of low public risk.

Fox Q3 Earnings Beat Despite Super Bowl Gap

Fox Q3 Earnings Beat Despite Super Bowl Gap

Fox Q3 earnings showed revenue fell y/y but the company beat on adjusted EPS as distribution gains and Tubi streaming offset ad weakness.